{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0002-7026",
      "generic_name": "pirtobrutinib",
      "labeler_name": "Eli Lilly and Company",
      "brand_name": "JAYPIRCA",
      "active_ingredients": [
        {
          "name": "PIRTOBRUTINIB",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0002-7026-60",
          "description": "60 TABLET, COATED in 1 BOTTLE (0002-7026-60)",
          "marketing_start_date": "20230127",
          "sample": false
        },
        {
          "package_ndc": "0002-7026-99",
          "description": "30 TABLET, COATED in 1 BOTTLE (0002-7026-99)",
          "marketing_start_date": "20230215",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "rxcui": [
          "2629343",
          "2629349",
          "2629351",
          "2629353"
        ],
        "spl_set_id": [
          "bd551845-0878-49a4-860f-839b83f6b801"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175605",
          "N0000193934",
          "N0000185503",
          "N0000187062",
          "N0000182140",
          "N0000190114",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Bruton's Tyrosine Kinase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Cytochrome P450 2C8 Inhibitors [MoA]",
          "Cytochrome P450 2C19 Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "JNA39I7ZVB"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, COATED",
      "spl_id": "ef421dc8-11db-4e6c-9154-dc04782cb52c",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230127",
      "product_id": "0002-7026_ef421dc8-11db-4e6c-9154-dc04782cb52c",
      "application_number": "NDA216059",
      "brand_name_base": "JAYPIRCA",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Bruton's Tyrosine Kinase Inhibitors [MoA]",
        "Cytochrome P450 2C19 Inhibitors [MoA]",
        "Cytochrome P450 2C8 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Kinase Inhibitor [EPC]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}